Search for: "Par Pharmaceutical, Inc."
Results 1 - 20
of 146
Sort by Relevance
|
Sort by Date
3 Jan 2025, 11:27 am
” Many successful Rule 702 motions have excluded the proffered opinion testimony of world-renown experts, which speaks volumes about how such experts think they can get away with sub-par work because it is only litigation. [read post]
3 Aug 2023, 3:03 am
In the case at issue, the appellant, Shopify Inc., appealed the decision of the GC T‑222/21, SHOPPI (already commented here), alleging infringement of Article 53(1) of EUTM Regulation no. 207/2009, in conjunction with Article 8(1)(b). [read post]
9 Jan 2023, 9:01 pm
Walgreens After more than seven years of litigation, Walgreens, Inc. [read post]
5 Jan 2023, 2:22 pm
The settlement ranks among the five largest securities settlements ever paid by a pharmaceutical manufacturer. [read post]
21 Aug 2022, 9:11 pm
Eagle Pharmaceuticals, Inc. [read post]
18 Aug 2022, 11:39 am
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
18 Aug 2022, 11:39 am
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
4 Jan 2022, 10:33 am
A Pennsylvania federal judge ordered California to pay nearly $80,000 in legal fees to Par Pharmaceutical Inc for failing to comply with discovery obligations in multidistrict litigation alleging a broad price-fixing conspiracy for generic drugs. [read post]
4 Jan 2022, 10:33 am
A Pennsylvania federal judge ordered California to pay nearly $80,000 in legal fees to Par Pharmaceutical Inc for failing to comply with discovery obligations in multidistrict litigation alleging a broad price-fixing conspiracy for generic drugs. [read post]
11 Nov 2021, 10:08 am
Par Pharmaceutical, Inc., 694 F.3d 1344 (Fed. [read post]
16 Sep 2021, 12:57 pm
Suffolk and Nassau Counties will each receive $13.85 million in combined settlements from Endo and its subsidiary Par Pharmaceutical, Inc. [read post]
18 Feb 2021, 7:49 pm
Hikma Pharmaceuticals USA Inc. [read post]
18 Feb 2020, 4:00 am
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan… [read post]
13 Jun 2019, 11:24 am
Facts: This case (Par Pharmaceutical, Inc. et al v. [read post]
14 May 2019, 11:24 am
” PAR Pharm., Inc.v. [read post]
8 May 2019, 7:14 am
Par Sterile Prod., LLC v. [read post]
15 Apr 2019, 7:19 pm
Par Pharmaceutical Inc., Nos. 14-1289-RGA, 14-1494-RGA, 15-0078-RGA (D. [read post]
17 Jul 2018, 9:28 am
” Par Pharmaceutical, Inc. v. [read post]
13 Jul 2018, 5:48 pm
Teva Pharmaceuticals USA, Inc., is apertinent intervening case, but did not explain how it isan intervening change in law to the inherency doctrine,especially given that it is an on-sale bar case. 855 F.3d1356 (Fed. [read post]
13 Jul 2018, 1:57 pm
., June 14, 2018, Animal Science Products, Inc. v. [read post]
